Characterization of Vibrio cholerae neuraminidase as an immunomodulator for novel formulation of oral allergy immunotherapy-Reference-Cited by-同舟云学术

Characterization of Vibrio cholerae neuraminidase as an immunomodulator for novel formulation of oral allergy immunotherapy

Published:2018-07 Issue: Volume:192 Page:30-39
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Diesner Susanne C.,Bergmayr Cornelia,Wang Xue-Yan,Heiden Denise,Exenberger Sarah,Roth-Walter Franziska,Starkl Philipp,Ret Davide,Pali-Schöll Isabella,Gabor Franz,Untersmayr Eva

Funder

Austrian Science fund

FWF

FRW and FG

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference38 articles.

1. Biopharmaceutic classification system: a scientific framework for pharmacokinetic optimization in drug research;Varma;Curr. Drug Metab.,2004

2. Use of lectin-functionalized particles for oral immunotherapy;Diesner;Ther. Deliv.,2012

3. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach;des Rieux;J. Control. Release,2006

4. Review of novel particulate antigen delivery systems with special focus on treatment of type I allergy;Schöll;J. Control. Release,2005

5. Biodegradable PLGA particles for improved systemic and mucosal treatment of Type I allergy;Schöll;Immunol. Allergy Clin. N. Am.,2006

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Geographical distribution and antibiotics susceptibility patterns of toxigenic Vibrio cholerae isolates from Kisumu County, Kenya;African Journal of Primary Health Care & Family Medicine;2020-12-08

2. New and novel approaches for enhancing the oral absorption and bioavailability of protein and peptides therapeutics;Therapeutic Delivery;2020-11

3. Immunotherapy in allergic diseases — improved understanding and innovation for enhanced effectiveness;Current Opinion in Immunology;2020-10

4. Advances and novel developments in molecular allergology;Allergy;2020-09-22

5. Overcoming the intestinal barrier: A look into targeting approaches for improved oral drug delivery systems;Journal of Controlled Release;2020-06